Explore more publications!

Press Releases

Advancing Bioethics and Medical Humanities 

Advancing Bioethics and Medical Humanities 

Shamrock Medicine Offers Comprehensive Family Medicine Services in Cherry Hill
Dresner Partners Advised Valley E.N.T. Associates and Masdon ENT & Facial Plastic Surgery on Their Sale to Confluence Healthcare Partners
Vertero Establishes Scientific Advisory Board to Advance Innovation in Neurodegenerative Diseases
Proactive MD Expands Access to Women’s Health and Chronic Disease Care with New Acquisitions
Curaechoice and Northwestern Memorial Healthcare Extend Partnership to Expand Access to No-Cost Healthcare for Curaechoice Members Nationwide
JAN-PRO Cleaning & Disinfecting in Central Alabama Highlights Guidance for Faster Carpet Drying in Commercial Facilities
GATC Health to Host Virtual KOL Event to Discuss Derisq™ AI Report: Predictive, Detailed Risk Assessment of Drug Candidates, on December 10, 2025
AKC Canine Health Foundation Announces Finalists for Inaugural Canine Health Discovery of the Year Award
ExperCARE Fuels Growth by Launching Integrated Urgent and Primary Care Model in Huntsville, Alabama
UnityPoint Health Announces Chief Medical Officer and Vice President for Oncology
IR Centers and Urology Associates of Mobile Launch Advanced Interventional Radiology Program in Alabama
Hospital Services Market Size Worth USD 24.17 Trillion by 2034 Driven by Expansion of Digital Health and Telemedicine
Two-Time Convicted Felon CEO and His Dietary Supplement Company Convicted of $4.7 Million Fraud Scheme

Two-Time Convicted Felon CEO and His Dietary Supplement Company Convicted of $4.7 Million Fraud Scheme

Trinity Marketing Services Partners with Cygenex to Advance Health Strategy with PGx Testing and Predictive Analytics
Vironix Expands Remote Care Services into Alabama, Deepening Presence Across the Southern U.S.
Cushman & Wakefield and Greystone Close Sale and Financing of Multifamily Acquisition in Alabama
Serina Therapeutics Strengthens Leadership Team with Appointment of Dr. Joshua Thomas as VP, Head of Chemistry
Kymera Therapeutics Announces Closing of Upsized $602 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Dyne Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions